Calendar

Financial Releases

Date Title  
Toggle Summary AbbVie to Present at Jefferies 2013 Healthcare Conference
NORTH CHICAGO, Ill. , Nov. 14, 2013 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the Jefferies 2013 Healthcare Conference on Thursday, Nov. 21, 2013 . Scott Brun , M.D., vice president, pharmaceutical development, will take part in a question and answer session at 10:40 a.m.
Toggle Summary AbbVie to Present at Credit Suisse 2013 Healthcare Conference
NORTH CHICAGO, Ill , Nov. 7, 2013 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the Credit Suisse 2013 Healthcare Conference on Thursday, Nov. 14, 2013 . Bill Chase , executive vice president and chief financial officer, and Scott Brun , M.D., vice president, pharmaceutical development,
Toggle Summary AbbVie Reports Third-Quarter 2013 Financial Results
NORTH CHICAGO, Ill. , Oct. 25, 2013 /PRNewswire/ -- Reports Third-Quarter Adjusted EPS of $0.82 , Above Previous Guidance Range ; GAAP EPS of $0.60 Raises 2013 Adjusted EPS Guidance to $3.11-$3.13 , GAAP EPS Guidance of $2.54-$2.56 Delivers Revenue of $4.658 Billion , an Increase of 3.3 Percent (Up
Toggle Summary AbbVie to Host Third-Quarter Earnings Conference Call
NORTH CHICAGO, Ill. , Oct. 4, 2013 /PRNewswire/ --  AbbVie (NYSE: ABBV) will announce its third-quarter 2013 financial results on Friday, Oct. 25, 2013 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time ( 9 a.m. Eastern).
Toggle Summary AbbVie Declares Quarterly Dividend
NORTH CHICAGO, Ill. , Sept. 19, 2013 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $0.40 per share.  The cash dividend is payable Nov. 15, 2013 to stockholders of record at the close of business on Oct. 15, 2013 .
Toggle Summary AbbVie to Present at Morgan Stanley Global Healthcare Conference
NORTH CHICAGO, Ill. , Aug. 27, 2013 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Morgan Stanley Global Healthcare Conference on Tuesday, Sept. 10, 2013 . Richard A. Gonzalez , chairman and chief executive officer, and Scott Brun , M.D., vice president, pharmaceutical development,
Toggle Summary AbbVie Reports Second-Quarter 2013 Financial Results
- Raises 2013 Adjusted EPS Guidance to $3.07-$3.13, GAAP EPS Guidance of $2.66-$2.72 - Reports Second-Quarter Adjusted EPS of $0.82, GAAP EPS of $0.66 - Delivers Revenue of $4.692 Billion, an Increase of 4.4 Percent (Up 5.1 Percent Excluding Foreign Exchange) - Revenue Growth Reflects 12.1 Percent
Toggle Summary AbbVie to Host Second-Quarter Earnings Conference Call
NORTH CHICAGO, Ill. , July 8, 2013 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its second-quarter 2013 financial results on Friday, July 26, 2013 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time ( 9 a.m. Eastern).
Toggle Summary AbbVie Declares Quarterly Dividend
NORTH CHICAGO, Ill. , June 20, 2013 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $0.40 per share.  The cash dividend is payable Aug. 15, 2013 to stockholders of record at the close of business on July 15, 2013 .
Toggle Summary AbbVie to Participate in 34th Annual Goldman Sachs Global Healthcare Conference
NORTH CHICAGO, Ill. , June 5, 2013 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the 34 th Annual Goldman Sachs Global Healthcare Conference on Thursday, June 13 , 2013.  Bill Chase , executive vice president and chief financial officer, and Scott Brun , M.D., vice president,